This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wattenberg, L. W. Articles by Estensen, R. D. Search for Related Content PubMed PubMed Citation Articles by Wattenberg, L. W. Articles by Estensen, R. D.

Chemoprevention of Cancer of the Upper Respiratory Tract of the Syrian Golden Hamster by Aerosol Administration of Difluoromethylornithine and 5-Fluorouracil

Departments of ¹ Laboratory Medicine and Pathology and ² Pharmaceutics, University of Minnesota, Minneapolis, Minnesota

Research aimed at identifying effective chemopreventive compounds active against carcinogenesis of the upper respiratory tract (URT) has been largely unsuccessful. We are addressing this problem by efforts at agent identification and by using aerosol delivery. Two compounds, difluoromethylornithine (DFMO) and 5-fluorouracil (5-FU) were investigated. DFMO is an irreversible inhibitor of ornithine decarboxylase, an enzyme important in cell proliferation. It has been used widely by oral administration for chemoprevention. 5-FU is a pyrimidine analog used extensively as a chemotherapeutic agent. It is generally administered i.v. and can cause considerable toxicity. However, aerosol administration for therapy of lung cancer in humans has been reported to be without adverse effects (Tatsumura et al., Br J Cancer 1993;68:1146–9). The experimental model used herein entailed six intratracheal administrations of methylnitrosourea (MNU) to hamsters. Each of the test agents was started about 1 week after MNU and was continued for 29 weeks with DFMO. Infiltrating squamous cell carcinomas of the URT occurred in 92% of the controls and were reduced by 50% in animals receiving DFMO (P = 0.0001). The experiment with 5-FU was of shorter duration being terminated 20 weeks after MNU. Thirty percent of the controls had infiltrating carcinomas and were reduced by 60% in animals receiving 5-FU (P = 0.0274). Both compounds resulted in a significant increase in the percent of cancer-free animals. These two agents may have selected use in subjects at high risk of cancer of the URT.

This article has been cited by other articles:

				M. W. Anderson, C. Goodin, Y. Zhang, S. Kim, R. D. Estensen, T. S. Wiedmann, P. Sekar, C. R. Buncher, J. C. Khoury, J. R. Garbow, et al. Effect of dietary green tea extract and aerosolized difluoromethylornithine during lung tumor progression in A/J strain mice Carcinogenesis, August 1, 2008; 29(8): 1594 - 1600. [Abstract] [Full Text] [PDF]

				R. D. Estensen, W. R. Anderson, A. R. Galbraith, D. E. Hartle, M. M. Jordan, F. G. Ondrey, and L. W. Wattenberg A Method of Producing Carcinoma in Upper Aerodigestive Tree and Esophagus of the Syrian Golden Hamster Using Wounding and Instillation of N-Methylnitrosourea Cancer Epidemiol. Biomarkers Prev., August 1, 2007; 16(8): 1644 - 1650. [Abstract] [Full Text] [PDF]

				F. Gagnadoux, A. L. Pape, E. Lemarie, S. Lerondel, I. Valo, V. Leblond, J-L. Racineux, and T. Urban Aerosol delivery of chemotherapy in an orthotopic model of lung cancer Eur. Respir. J., October 1, 2005; 26(4): 657 - 661. [Abstract] [Full Text] [PDF]